Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Global | Publication | January 2021
Norton Rose Fulbright contributed to this report written by the World Business Council for Sustainable Development (WBCSD). Other contributing authors include Schneider Electric, DNV GL and RECS International.
This report builds on previous reports on corporate power purchase agreements (PPAs): Corporate Renewable Power Purchase Agreements: Scaling up globally (October 2016), Innovation in Power Purchase Agreement Structures (March 2018) and How multi-technology PPA structures could help companies reduce risk (March 2019). These reports cover the opportunities corporate PPAs offer, the obstacles that corporate buyers and developers face as they plan and negotiate PPAs, as well as innovations in corporate PPAs as the market grows and evolves. This paper adds an additional focus to the previous publications and aims to help companies understand the technicalities of cross-border PPAs by providing a balanced view of the risks and opportunities that the cross-border PPA structure can provide.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025